These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 33910777

  • 1. 10-Year survey on serum antibody positivity rates and titers for measles and rubella in healthcare workers; an observational study at a Japanese university hospital.
    Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Yoshida H, Hamaguchi S, Maeda I, Hidaka Y, Tomono K.
    J Infect Chemother; 2021 Sep; 27(9):1295-1299. PubMed ID: 33910777
    [Abstract] [Full Text] [Related]

  • 2. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    Ogawa T, Inoue T, Kasahara K, Konishi M, Mikasa K.
    PLoS One; 2020 Sep; 15(3):e0230329. PubMed ID: 32208432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of vaccine program on IgG antibody titers for measles, rubella, varicella, and mumps in young adults in Japan: Survey between 2018 and 2021.
    Miyazaki H, Yamanaka G, Furukawa K, Ichiki M.
    J Infect Chemother; 2022 Oct; 28(10):1410-1414. PubMed ID: 35779802
    [Abstract] [Full Text] [Related]

  • 5. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S, Feyssaguet M, Povey M, Di Paolo E.
    Vaccine; 2019 Aug 23; 37(36):5323-5331. PubMed ID: 31345639
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of antibody titer of measles and rubella virus among university students of department of healthcare providers during 2015-2018 in Japan.
    Kurita J, Uematsu T, Sakurai N, Sugawara T, Ohkusa Y, Yamaguchi N.
    Vaccine; 2021 Jul 05; 39(30):4203-4209. PubMed ID: 34120763
    [Abstract] [Full Text] [Related]

  • 7. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M, Hisano M, Watanabe N, Sugawara K, Kambe Y, Kanda E, Sago H, Kato T, Yamaguchi K.
    Vaccine; 2013 May 01; 31(19):2343-7. PubMed ID: 23523405
    [Abstract] [Full Text] [Related]

  • 8. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M.
    Tohoku J Exp Med; 2014 Oct 01; 234(2):111-6. PubMed ID: 25224029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Oct 01; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 11. Vaccination strategy for epidemic viral diseases in healthcare workers: Cut-off for optimal immunization.
    Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Tomono K.
    J Infect Chemother; 2019 Jan 01; 25(1):78-81. PubMed ID: 30064948
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.
    Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M.
    Epidemiol Infect; 2014 Jan 01; 142(1):12-9. PubMed ID: 23574767
    [Abstract] [Full Text] [Related]

  • 13. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
    Haralambieva IH, Ovsyannikova IG, Kennedy RB, Goergen KM, Grill DE, Chen MH, Hao L, Icenogle J, Poland GA.
    Vaccine; 2020 Jan 29; 38(5):1249-1257. PubMed ID: 31732325
    [Abstract] [Full Text] [Related]

  • 14. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.
    Vaccine; 2018 Feb 01; 36(6):818-826. PubMed ID: 29317117
    [Abstract] [Full Text] [Related]

  • 15. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.
    J Infect Dis; 2016 Jun 15; 213(12):2005-13. PubMed ID: 26908733
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S.
    Infect Control Hosp Epidemiol; 2004 Jul 15; 25(7):591-4. PubMed ID: 15301032
    [Abstract] [Full Text] [Related]

  • 17. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
    Karadeniz A, Akduman Alaşehir E.
    J Infect Public Health; 2020 Apr 15; 13(4):480-484. PubMed ID: 32113699
    [Abstract] [Full Text] [Related]

  • 18. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug 15; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 19. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
    McLean HQ, Fiebelkorn AP, Ogee-Nwankwo A, Hao L, Coleman LA, Adebayo A, Icenogle JP.
    Vaccine; 2018 Sep 11; 36(38):5732-5737. PubMed ID: 30107992
    [Abstract] [Full Text] [Related]

  • 20. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N, Puenpa J, Thongmee T, Srimuan D, Thatsanathorn T, Vongpunsawad S, Poovorawan Y.
    Vaccine; 2020 May 19; 38(24):4016-4023. PubMed ID: 32331806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.